| |
A high R&D productivity institution
José A.
Acosta, Ernesto L. Mola, Ricardo S. Rodríguez, Boris
E. Acevedo
Department of Business and Project Development, CIGB.
A high R&D productivity institution
Havana ,15 january 2005. A recent study on the Center for Genetic Engineering and Biotec hnology (CIGB), Havana , Cuba , has revealed a growing trend in the number of scientific publications, during the last 15 years. From 1988 to 2003, the CIGB published 681 peer-reviewed papers in scientific journals, according to the ISI Web of Knowledge ( http://wok.mimas.ac.uk ) and the Science Citation Index ( http://www.isinet.com ). The most significant growing period was between 1991 and 1995, when the growth rate of article production was between 16 and 125%/y . From 1997 to 1999, similar results were obtained, fluctuating between 35 and 90%/y . It is also worth noting that the CIGB's articles have been cited in more than 3130 papers, from 1988 to 2004. These results demonstrate that the CIGB's scientific publications have been very useful for researchers of the life sciences and the worldwide medical community.
As a result of a growing R&D productivity, the CIGB's pipeline is becoming stronger than 10 years ago. At present, there are 2.4-fold more products in the market than in the 90s. Scientists at CIGB are developing the CITOPROT-P product, supported by a PCT patent application of use for a pharmaceutical composition in a parenteral formulation, which is administered for diabetic foot amputation prevention. On the other hand, the Cuban vaccine for Haemophilus influenzae type b has been evaluated in 7 clinical trials, 2 in adults, 2 in children 4 years old and 3 in newborns. The efficacy in the induction of long-term protection in newborns was almost 100%.
Acuabio 1 is another new product developed by the CIGB that promotes significant improvements regarding optimal growth and better health in aquatic organisms. When tested in shrimps, standard size and weight of whole shrimps population, during shrimp farming, increase 130% in larvae stage and 40% in adults. These are a few of many scientific results obtained by the high productivity staff working at the CIGB.
The CIGB is looking for s trategic alliances in research and development from potential partners to speed up our R&D project Portfolio. The CIGB's negotiation Portfolio, involving 20 biomedical and agriculture projects, has been published in the web site http://gndp.cigb.edu.cu , to facilitate the access to the medical community, companies and research institutions to the most up to date R&D advances at CIGB.
For information: http://gndp.cigb.edu.cu or http://www.cigb.edu.cu
Contact: ernesto.lopez@cigb.edu.cu
Phone: (53-7) 2712397.
|
|
